Repository logo
 
Publication

Bisphenol A at the reference level counteracts doxorubicin transcriptional effects on cancer related genes in HT29 cells

2015-12Journal article Restricted access
Simple item page
dc.contributor.authorDelgado, Margarida
dc.contributor.authorRibeiro-Varandas, Edna
dc.date.accessioned2015-09-29T10:34:19Z
dc.date.available2015-09-29T10:34:19Z
dc.date.issued2015-12
dc.description.abstractHuman exposure to Bisphenol A (BPA) results mainly from ingestion of food and beverages. Information regarding BPA effects on colon cancer, one of the major causes of death in developed countries, is still scarce. Likewise, little is known about BPA drug interactions although its potential role in doxorubicin (DOX) chemoresistance has been suggested. This study aims to assess potential interactions between BPA and DOX on HT29 colon cancer cells. HT29 cell response was evaluated after exposure to BPA, DOX, or co-exposure to both chemicals. Transcriptional analysis of several cancer-associated genes (c-fos, AURKA, p21, bcl-xl and CLU) shows that BPA exposure induces slight up-regulation exclusively of bcl-xl without affecting cell viability. On the other hand, a sub-therapeutic DOX concentration (40nM) results in highly altered c-fos, bcl-xl, and CLU transcript levels, and this is not affected by co-exposure with BPA. Conversely, DOX at a therapeutic concentration (4μM) results in distinct and very severe transcriptional alterations of c-fos, AURKA, p21 and CLU that are counteracted by co-exposure with BPA resulting in transcript levels similar to those of control. Co-exposure with BPA slightly decreases apoptosis in relation to DOX 4μM alone without affecting DOX-induced loss of cell viability. These results suggest that BPA exposure can influence chemotherapy outcomes and therefore emphasize the necessity of a better understanding of BPA interactions with chemotherapeutic agents in the context of risk assessment.pt_PT
dc.identifier.citationDelgado M, Ribeiro-Varandas E. Bisphenol A at the reference level counteracts doxorubicin transcriptional effects on cancer related genes in HT29 cells. Toxicol in Vitro. 2015;29(8):2009-14.pt_PT
dc.identifier.doi10.1016/j.tiv.2015.08.016
dc.identifier.urihttp://hdl.handle.net/10400.21/5224
dc.language.isoengpt_PT
dc.peerreviewedyespt_PT
dc.publisherElsevierpt_PT
dc.relation.publisherversionhttp://www.sciencedirect.com/science/article/pii/S0887233315002118pt_PT
dc.subjectBisphenol Apt_PT
dc.subjectDoxorubicinpt_PT
dc.subjectHT29 cell linept_PT
dc.subjectDrug interactionpt_PT
dc.subjectGene transcriptionpt_PT
dc.titleBisphenol A at the reference level counteracts doxorubicin transcriptional effects on cancer related genes in HT29 cellspt_PT
dc.typejournal article
dspace.entity.typePublication
oaire.citation.endPage2014pt_PT
oaire.citation.startPage2009pt_PT
oaire.citation.titleToxicology in Vitropt_PT
oaire.citation.volume29pt_PT
rcaap.rightsrestrictedAccesspt_PT
rcaap.typearticlept_PT

Files

Original bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
Bisphenol A at the reference level counteracts Doxorubicin transcriptional effects on cancer related genes in HT29 cells.pdf
Size:
796.56 KB
Format:
Adobe Portable Document Format
Download
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description:
Download

Collections

ESTeSL - Artigos